When the percentages were calculated considering the cancer staging in both lung and prostate cancer patients the percentages of decrement were found to be higher in later stages compared with early stages and this mostly due to the fact that the starting α1-AT blood levels in late stages is much higher compared with early stages. The gene discussed is SERPINA1; the disease is prostate carcinoma.